Return of Lead Compounds to Cortex Sample Clauses
Return of Lead Compounds to Cortex. Upon commencement of a ---------------------------------- Phase III Study by Shire for the first Product, Shire shall deselect Lead Compounds such that it retains no more than [*] Lead Compounds and any so deselected compounds shall be returned to Cortex. Upon filing of the NDA by Shire in the United States, Shire shall deselect Lead Compounds such that it retains no more than [*] Lead Compounds and any compounds so deselected shall be returned to Cortex. Upon the approval by the FDA of the first Product for commercialization in the United States, Shire shall deselect Lead Compounds such that it retains no more than [*] Lead Compounds and any so deselected compounds shall be returned to Cortex. The choice of which Lead Compounds to deselect by Shire pursuant to this Section 3 shall be at Shire's sole discretion. All rights to deselected Compounds shall revert immediately back to Cortex, and Cortex shall be free to use all such compounds for all purposes and may grant rights to such compounds to Third Parties for use outside, but not inside, the Field. When rights to a Lead Compound reverts to Cortex pursuant to this Section 3.4, Shire agrees, at the cost of Cortex, to execute and deliver such instruments and take such other actions as Cortex shall reasonably request in order to carry out the transfer of such rights to Cortex.
Return of Lead Compounds to Cortex. All rights to Cortex and ---------------------------------- Collaboration Compounds which have not been selected as Lead Compounds in accordance with Articles 3.4.1 and 3.4.2 hereabove shall revert immediately back to Cortex, and Cortex shall be free to use all such compounds for all purposes and may grant rights to such compounds to Third Parties for any use outside the Territory, and for any use outside the Field inside the Territory. When rights to a Cortex Compound or a Collaboration Compound reverts to Cortex pursuant to this Article 3.4, Servier agrees to execute and deliver such instruments and take such other actions as Cortex shall reasonably request in order to carry out the transfer of such rights, including any interest of Servier in Joint Inventions relating to such compounds, to Cortex.